Saint Davids, PA, United States of America

Renee L DesJarlais


 

Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2010-2014

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: **Renee L DesJarlais: Innovator in Pharmaceutical Research**

Introduction

Renee L DesJarlais is a prominent inventor based in Saint Davids, PA, recognized for her significant contributions to the field of pharmaceutical research. With an impressive portfolio of seven patents, her work primarily focuses on the development of innovative methods and compounds aimed at treating various cell proliferative disorders, including cancers.

Latest Patents

One of her latest patents is titled "Method of inhibiting C-KIT kinase." This invention outlines a method of reducing or inhibiting kinase activity of C-KIT in a cell or a subject, which plays a crucial role in preventing or treating cell proliferative disorders. The patent specifies the use of compounds, including solvates, hydrates, tautomers, or pharmaceutically acceptable salts, to achieve therapeutic effects.

Another noteworthy patent by DesJarlais is "4,4-disubstituted piperidine derivatives useful as inhibitors of dipeptidyl peptidase-1 (DPP-1)." This invention focuses on the development of 4,4-di-substituted piperidine derivatives and their pharmaceutical compositions. The patent highlights their application in treating disorders and conditions modulated by DPP-1, which are critical for advancing therapeutic options in healthcare.

Career Highlights

Renee L DesJarlais currently works at Janssen Pharmaceutica N.V., a leader in pharmaceutical advancements. Her innovative inventions contribute to the company's efforts in addressing unmet medical needs through cutting-edge therapies. Her research and developments have played a pivotal role in enhancing our understanding of cancer treatments and cell proliferation.

Collaborations

Throughout her career, DesJarlais has collaborated with notable coworkers such as Dennis J Hlasta and Carl R Illig. These partnerships have fostered a dynamic research environment, enabling the exploration of novel therapeutic solutions and enhancing the effectiveness of their collective projects.

Conclusion

Renee L DesJarlais exemplifies the spirit of innovation in the pharmaceutical industry. Her extensive work in developing new treatment methods not only showcases her expertise but also represents a significant advancement in the fight against cell proliferative disorders. As she continues to contribute her knowledge and creative solutions, her impact on healthcare will undoubtedly be felt for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…